165 related articles for article (PubMed ID: 16204959)
1. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.
Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K
Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959
[TBL] [Abstract][Full Text] [Related]
2. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells.
Sun YF; Wink M
Phytomedicine; 2014; 21(8-9):1110-9. PubMed ID: 24856768
[TBL] [Abstract][Full Text] [Related]
3. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
[TBL] [Abstract][Full Text] [Related]
4. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
[TBL] [Abstract][Full Text] [Related]
5. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.
Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M
J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879
[TBL] [Abstract][Full Text] [Related]
6. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
Wang L; Kitaichi K; Hui CS; Takagi K; Takagi K; Sakai M; Yokogawa K; Miyamoto KI; Hasegawa T
Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):587-93. PubMed ID: 10901387
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855
[TBL] [Abstract][Full Text] [Related]
8. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
Kataoka Y; Ishikawa M; Miura M; Takeshita M; Fujita R; Furusawa S; Takayanagi M; Takayanagi Y; Sasaki K
Biol Pharm Bull; 2001 Jun; 24(6):612-7. PubMed ID: 11411546
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine).
Adams DJ; Knick VC
Invest New Drugs; 1995; 13(1):13-21. PubMed ID: 7499103
[TBL] [Abstract][Full Text] [Related]
10. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
[TBL] [Abstract][Full Text] [Related]
11. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
Zhu X; Sui M; Fan W
Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
[TBL] [Abstract][Full Text] [Related]
13. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
Quesada AR; García Grávalos MD; Fernández Puentes JL
Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
[TBL] [Abstract][Full Text] [Related]
14. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
[TBL] [Abstract][Full Text] [Related]
15. Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.
Long QZ; Zhou M; Liu XG; Du YF; Fan JH; Li X; He DL
Anticancer Drugs; 2013 Sep; 24(8):810-7. PubMed ID: 23744557
[TBL] [Abstract][Full Text] [Related]
16. Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein.
Mayer LD; Lim KT; Hartley D
J Exp Ther Oncol; 2002; 2(2):107-20. PubMed ID: 12415627
[TBL] [Abstract][Full Text] [Related]
17. The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein.
Choi SU; Park SH; Kim KH; Choi EJ; Kim S; Park WK; Zhang YH; Kim HS; Jung NP; Lee CO
Anticancer Drugs; 1998 Mar; 9(3):255-61. PubMed ID: 9625436
[TBL] [Abstract][Full Text] [Related]
18. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
[TBL] [Abstract][Full Text] [Related]
19. Drug accumulation in the presence of the multidrug resistance pump: dissociation between verapamil accumulation and the action of P-glycoprotein.
Ayesh S; Litman T; Stein WD
Recept Channels; 1997; 5(3-4):175-83. PubMed ID: 9606721
[TBL] [Abstract][Full Text] [Related]
20. Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer.
He P; Sun H; Jian XX; Chen QH; Chen DL; Liu GT; Wang FP
J Asian Nat Prod Res; 2012; 14(6):564-76. PubMed ID: 22587798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]